Patent details

Basic Information

Publication number:

EP2567693

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121911549

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Lipid encapsulated interfering RNA

French Title of Invention:

ARN interférents encapsulés dans des lipides

German Title of Invention:

Interferierende, in Lipiden eingekapselte RNA

SPC Number:

Dates

Filing date:

16/07/2004

Grant date:

21/10/2015

EP Publication Date:

21/10/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/03/2013

EP B1 Publication Date:

21/10/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/07/2016

Expiration date:

16/07/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/07/2004

 

 

Name:

Protiva Biotherapeutics Inc.

Address:

100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8, Canada (CA)

Inventor

1

Name:

Ambegia Ellen Grace

Address:

Canada (CA)

2

Name:

Heyes James

Address:

Canada (CA)

3

Name:

MacLachlan Ian

Address:

Canada (CA)

Priority

1

Priority Number:

488144 P

Priority Date:

16/07/2003

Priority Country:

United States (US)

2

Priority Number:

503279 P

Priority Date:

15/09/2003

Priority Country:

United States (US)

3

Priority Number:

529406 P

Priority Date:

11/12/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/127;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages